Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
96.10
-11.30 (-10.52%)
At close: Mar 9, 2026

Cosmo Pharmaceuticals Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
55.8744.350.28185.83198.56
Upgrade
Short-Term Investments
-17.99-52.7-
Upgrade
Trading Asset Securities
-80.68-2.4323.65
Upgrade
Cash & Short-Term Investments
55.87142.9650.28240.95222.21
Upgrade
Cash Growth
-60.92%184.36%-79.14%8.44%4.40%
Upgrade
Accounts Receivable
24.1418.9428.4538.6124.45
Upgrade
Other Receivables
25.951.682.222.693.23
Upgrade
Receivables
50.0920.6230.6741.327.68
Upgrade
Inventory
10.4313.5114.211.513.12
Upgrade
Prepaid Expenses
-15.23.323.061.96
Upgrade
Other Current Assets
66.899.973.769.2810.88
Upgrade
Total Current Assets
183.28202.26102.23306.1275.85
Upgrade
Property, Plant & Equipment
30.8129.0928.5930.2830.48
Upgrade
Long-Term Investments
-31.843.298.2749.08
Upgrade
Goodwill
24.0124.0124.0124.0124.01
Upgrade
Other Intangible Assets
325.88161.66116.15360.89369.31
Upgrade
Long-Term Deferred Tax Assets
19.8918.7219.8314.6818.64
Upgrade
Long-Term Deferred Charges
-170.27222.215.53.42
Upgrade
Other Long-Term Assets
28.778.949.759.879.78
Upgrade
Total Assets
612.64646.77526.05759.59805.56
Upgrade
Accounts Payable
11.339.18.787.598.3
Upgrade
Accrued Expenses
-3.426.025.95.25
Upgrade
Short-Term Debt
0.71----
Upgrade
Current Portion of Long-Term Debt
-0.140.14171.070.13
Upgrade
Current Portion of Leases
-0.680.760.760.76
Upgrade
Current Income Taxes Payable
0.6219.952.172.293.25
Upgrade
Other Current Liabilities
12.8714.987.257.353.55
Upgrade
Total Current Liabilities
25.5248.2725.12194.9521.24
Upgrade
Long-Term Debt
3.560.280.420.56167.15
Upgrade
Long-Term Leases
-1.10.521.211.88
Upgrade
Pension & Post-Retirement Benefits
0.580.650.560.410.48
Upgrade
Long-Term Deferred Tax Liabilities
9390.8192.6197.199.75
Upgrade
Other Long-Term Liabilities
0.80.573.21.582.39
Upgrade
Total Liabilities
123.46141.68122.42295.8292.88
Upgrade
Common Stock
4.564.564.564.564.56
Upgrade
Additional Paid-In Capital
243.57243.57243.57243.57243.57
Upgrade
Retained Earnings
316.1373.6271.18310.09341.16
Upgrade
Treasury Stock
--104.11-101.31-89.8-65.56
Upgrade
Comprehensive Income & Other
-81.93-19.28-21.18-11.49-18.45
Upgrade
Total Common Equity
482.3498.33396.82456.93505.28
Upgrade
Minority Interest
6.886.766.816.867.4
Upgrade
Shareholders' Equity
489.18505.09403.62463.79512.68
Upgrade
Total Liabilities & Equity
612.64646.77526.05759.59805.56
Upgrade
Total Debt
4.272.21.84173.6169.92
Upgrade
Net Cash (Debt)
51.6140.7648.4467.3652.29
Upgrade
Net Cash Growth
-63.34%190.61%-28.09%28.81%16.96%
Upgrade
Net Cash Per Share
3.238.573.014.103.09
Upgrade
Filing Date Shares Outstanding
15.9616.0216.0516.2616.71
Upgrade
Total Common Shares Outstanding
15.9616.0216.0516.2616.71
Upgrade
Working Capital
157.76153.9977.11111.15254.61
Upgrade
Book Value Per Share
30.2231.1224.7228.1030.24
Upgrade
Tangible Book Value
132.41312.67256.6672.04111.96
Upgrade
Tangible Book Value Per Share
8.3019.5215.994.436.70
Upgrade
Land
-24.6425.0124.9724.02
Upgrade
Machinery
-50.7447.9545.1440.16
Upgrade
Construction In Progress
-1.41--1.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.